There is an interesting bit of news on the NCF page.
https://www.ncf-net.org/
The link from December leads to an article about a patent issued by Dr Kenny DeMeirleir for the increase of asparaginyl beta-hydroxylase (ASPH) in the cells of patients. It's in the link title
" NCF appeals to...
Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance
Mira Meeus 1, Jo Nijs, Neil McGregor, Romain Meeusen, Guy De Schutter, Steven Truijen, Marc Frémont...
https://www.fiercebiotech.com/biotech/fda-rejects-gilead-s-would-be-blockbuster-filgotinib-over-toxicity-concerns
Testicular toxicity!
Wow—This is the drug KDM was promoting, and planning to do trials with.
See here...
Submissions are now sought for a special journal edition, "ME/CFS - The Severely & Very Severely Affected"
Guest Editors:
Dr. Kenneth Friedman
Laboratory Corporation of America Holdings, Burlington, United States
Dr. Lucinda Bateman
Bateman Horne Center, Salt Lake City, United States
Prof...
KDM will give the opening speech at an immunology conference in Madrid, August, 6th with the exciting title : Biomarkers which identify CFS/ME patients
The announcement of the conference
https://immunology.immunologyconferences.org/
The program...
Put this in the biomed ME sub-forum as ME is one of the articles tags and one of the authors is De Meirleir.
Paywalled at https://www.sciencedirect.com/science/article/pii/S0955286318301761?via%3Dihub
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.